149 related articles for article (PubMed ID: 22684996)
1. Regulatory T cells participate in CD39-mediated protection from renal injury.
Wang YM; McRae JL; Robson SC; Cowan PJ; Zhang GY; Hu M; Polhill T; Wang Y; Zheng G; Wang Y; Lee VW; Unwin RJ; Harris DC; Dwyer KM; Alexander SI
Eur J Immunol; 2012 Sep; 42(9):2441-51. PubMed ID: 22684996
[TBL] [Abstract][Full Text] [Related]
2. CD39+Foxp3+ regulatory T Cells suppress pathogenic Th17 cells and are impaired in multiple sclerosis.
Fletcher JM; Lonergan R; Costelloe L; Kinsella K; Moran B; O'Farrelly C; Tubridy N; Mills KH
J Immunol; 2009 Dec; 183(11):7602-10. PubMed ID: 19917691
[TBL] [Abstract][Full Text] [Related]
3. CD39+ regulatory T cells attenuate allergic airway inflammation.
Li P; Gao Y; Cao J; Wang W; Chen Y; Zhang G; Robson SC; Wu Y; Yang J
Clin Exp Allergy; 2015 Jun; 45(6):1126-37. PubMed ID: 25728362
[TBL] [Abstract][Full Text] [Related]
4. CD4+CD25+ regulatory T cells attenuate cisplatin-induced nephrotoxicity in mice.
Lee H; Nho D; Chung HS; Lee H; Shin MK; Kim SH; Bae H
Kidney Int; 2010 Dec; 78(11):1100-9. PubMed ID: 20463654
[TBL] [Abstract][Full Text] [Related]
5. Regulatory T cells regulate the distribution of natural killer T cells through CD39 signal transduction in asthma.
Lu Y; Li Y; Zhou W; Ding B; Yu Q
Hum Cell; 2019 Apr; 32(2):141-149. PubMed ID: 30539423
[TBL] [Abstract][Full Text] [Related]
6. Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression.
Borsellino G; Kleinewietfeld M; Di Mitri D; Sternjak A; Diamantini A; Giometto R; Höpner S; Centonze D; Bernardi G; Dell'Acqua ML; Rossini PM; Battistini L; Rötzschke O; Falk K
Blood; 2007 Aug; 110(4):1225-32. PubMed ID: 17449799
[TBL] [Abstract][Full Text] [Related]
7. The abnormal function of CD39
Lu Y; Cheng L; Li F; Ji L; Shao X; Wu B; Zhan Y; Liu C; Min Z; Ke Y; Sun L; Chen H; Cheng Y
Ann Hematol; 2019 Aug; 98(8):1845-1854. PubMed ID: 31154474
[TBL] [Abstract][Full Text] [Related]
8. IL-35 stimulation of CD39+ regulatory T cells confers protection against collagen II-induced arthritis via the production of IL-10.
Kochetkova I; Golden S; Holderness K; Callis G; Pascual DW
J Immunol; 2010 Jun; 184(12):7144-53. PubMed ID: 20483737
[TBL] [Abstract][Full Text] [Related]
9. Regulation of innate immunity by the nucleotide pathway in children with idiopathic nephrotic syndrome.
Bertelli R; Bodria M; Nobile M; Alloisio S; Barbieri R; Montobbio G; Patrone P; Ghiggeri GM
Clin Exp Immunol; 2011 Oct; 166(1):55-63. PubMed ID: 21762125
[TBL] [Abstract][Full Text] [Related]
10. Regulatory T cells negatively affect IL-2 production of effector T cells through CD39/adenosine pathway in HIV infection.
Jenabian MA; Seddiki N; Yatim A; Carriere M; Hulin A; Younas M; Ghadimi E; Kök A; Routy JP; Tremblay A; Sévigny J; Lelievre JD; Levy Y
PLoS Pathog; 2013; 9(4):e1003319. PubMed ID: 23658513
[TBL] [Abstract][Full Text] [Related]
11. Human follicular lymphoma CD39+-infiltrating T cells contribute to adenosine-mediated T cell hyporesponsiveness.
Hilchey SP; Kobie JJ; Cochran MR; Secor-Socha S; Wang JC; Hyrien O; Burack WR; Mosmann TR; Quataert SA; Bernstein SH
J Immunol; 2009 Nov; 183(10):6157-66. PubMed ID: 19864600
[TBL] [Abstract][Full Text] [Related]
12. Natural killer T cell dysfunction in CD39-null mice protects against concanavalin A-induced hepatitis.
Beldi G; Wu Y; Banz Y; Nowak M; Miller L; Enjyoji K; Haschemi A; Yegutkin GG; Candinas D; Exley M; Robson SC
Hepatology; 2008 Sep; 48(3):841-52. PubMed ID: 18752325
[TBL] [Abstract][Full Text] [Related]
13. Dysfunctional CD39(POS) regulatory T cells and aberrant control of T-helper type 17 cells in autoimmune hepatitis.
Grant CR; Liberal R; Holder BS; Cardone J; Ma Y; Robson SC; Mieli-Vergani G; Vergani D; Longhi MS
Hepatology; 2014 Mar; 59(3):1007-15. PubMed ID: 23787765
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the expression and function of the P2X7 receptor and ART1 in human regulatory T-cell subsets.
Cortés-Garcia JD; López-López C; Cortez-Espinosa N; García-Hernández MH; Guzmán-Flores JM; Layseca-Espinosa E; Portales-Cervantes L; Portales-Pérez DP
Immunobiology; 2016 Jan; 221(1):84-93. PubMed ID: 26307000
[TBL] [Abstract][Full Text] [Related]
15. Phenotypic and functional characteristics of CD4+ CD39+ FOXP3+ and CD4+ CD39+ FOXP3neg T-cell subsets in cancer patients.
Schuler PJ; Schilling B; Harasymczuk M; Hoffmann TK; Johnson J; Lang S; Whiteside TL
Eur J Immunol; 2012 Jul; 42(7):1876-85. PubMed ID: 22585562
[TBL] [Abstract][Full Text] [Related]
16. Regulatory T cells in transplantation: does extracellular adenosine triphosphate metabolism through CD39 play a crucial role?
Salcido-Ochoa F; Tsang J; Tam P; Falk K; Rotzschke O
Transplant Rev (Orlando); 2010 Apr; 24(2):52-66. PubMed ID: 20153159
[TBL] [Abstract][Full Text] [Related]
17. Activated regulatory T-cells attenuate myocardial ischaemia/reperfusion injury through a CD39-dependent mechanism.
Xia N; Jiao J; Tang TT; Lv BJ; Lu YZ; Wang KJ; Zhu ZF; Mao XB; Nie SF; Wang Q; Tu X; Xiao H; Liao YH; Shi GP; Cheng X
Clin Sci (Lond); 2015 May; 128(10):679-93. PubMed ID: 25558978
[TBL] [Abstract][Full Text] [Related]
18. CD39 is involved in mediating suppression by Mycobacterium bovis BCG-activated human CD8(+) CD39(+) regulatory T cells.
Boer MC; van Meijgaarden KE; Bastid J; Ottenhoff TH; Joosten SA
Eur J Immunol; 2013 Jul; 43(7):1925-32. PubMed ID: 23606272
[TBL] [Abstract][Full Text] [Related]
19. Isolated CD39 expression on CD4+ T cells denotes both regulatory and memory populations.
Zhou Q; Yan J; Putheti P; Wu Y; Sun X; Toxavidis V; Tigges J; Kassam N; Enjyoji K; Robson SC; Strom TB; Gao W
Am J Transplant; 2009 Oct; 9(10):2303-11. PubMed ID: 19656134
[TBL] [Abstract][Full Text] [Related]
20. CD4+CD25+ regulatory T cells suppress contact hypersensitivity reactions through a CD39, adenosine-dependent mechanism.
Ring S; Oliver SJ; Cronstein BN; Enk AH; Mahnke K
J Allergy Clin Immunol; 2009 Jun; 123(6):1287-96.e2. PubMed ID: 19427686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
